Figure 3From: Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infectionEffect of telmisartan (TELM; 10 mg/ kg/ day, for 5 weeks), praziquantel (PZQ; 500 mg/ kg/ day, for 2 consecutive days), and their combination on the serum levels of aspartate transaminase (AST) in U/L of Schistosma mansoni -infected mice sacrificed at the 10th(set 1) and 15th(set 2) weeks post infection. All values are mean ± S.E.M. Significantly different (P<0.05) # versus normal non-infected group, * versus infected control group, @ versus TELM-treated group, and † versus PZQ-treated group.Back to article page